Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 3Recruiting 2Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 14Prostatic Neoplasms 7Breast Neoplasms 7Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Hematologic Neoplasms 4Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Myasthenia Gravis 3Melanoma 3Lung Neoplasms 3Leukemia 3Uterine Cervical Neoplasms 2Smoking 2Skin Neoplasms 2Ovarian Neoplasms 2Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myeloid, Acute 2Hematologic Diseases 2Esophageal Neoplasms 2Disease 2Carcinoma, Renal Cell 2Carcinoma 2Brain Neoplasms 2Anemia 2Adenocarcinoma 2von Hippel-Lindau Disease 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Diabetes Mellitus, Type 2 × 30 days × Clear all
NCT05785780 2026-05-29

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Rutgers, The State University of New Jersey

Phase NA Enrolling by invitation
30 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡